Background: Toll-like receptors (TLRs) are crucial for recognition of pathogen-associated molecular patterns by cells of the innate immune system. TLRs are present and functional in CD4 + T cells. Memory CD4 + T cells, predominantly central memory cells (TCM), constitute the main reservoir of latent HIV-1. However, how TLR ligands affect the quiescence of latent HIV within central memory CD4 + T cells has not been studied. Results: We evaluated the ability of a broad panel of TLR agonists to reactivate latent HIV-1. The TLR-1/2 agonist Pam3CSK4 leads to viral reactivation of quiescent HIV in a model of latency based on cultured TCM and in resting CD4 + T cells isolated from aviremic patients. In addition, we investigated the signaling pathw...
Latent HIV-1 proviruses are capable of reactivating productive lytic infection, but the precise mole...
Combination antiretroviral therapy (cART) can effectively suppress HIV-1 replication, but the latent...
Combination antiretroviral therapy (cART) can effectively suppress HIV-1 replication, but the latent...
Abstract Background Toll-like receptors (TLRs) are crucial for recognition of pathogen-associated mo...
Background Toll-like receptors (TLRs) are crucial for recognition of pathogen-associated molecular p...
Toll-like receptors (TLRs) are crucial for recognition of pathogen-associated molecular patterns by ...
The use of antiretroviral therapy in HIV type 1 (HIV-1)–infected patients does not lead to virus era...
The persistence of latently HIV-infected cells in patients under combined anti-retroviral treatment ...
Background: The latent HIV-1 reservoir in treated patients primarily consists of resting memory CD4 ...
Background: The latent HIV-1 reservoir in treated patients primarily consists of resting memory CD4+...
BACKGROUND: During combined anti-retroviral treatment, a latent HIV reservoir persists within restin...
Highly active antiretroviral therapy (HAART) can reduce plasma HIV-1 levels in infected individuals ...
The biomolecular mechanisms controlling latent HIV-1 infection, despite their importance for the dev...
Background: Combination antiretroviral therapy (cART) is able to control HIV-1 viral replication, ho...
The search for an HIV-1 cure has been greatly hindered by the presence of a viral reservoir that per...
Latent HIV-1 proviruses are capable of reactivating productive lytic infection, but the precise mole...
Combination antiretroviral therapy (cART) can effectively suppress HIV-1 replication, but the latent...
Combination antiretroviral therapy (cART) can effectively suppress HIV-1 replication, but the latent...
Abstract Background Toll-like receptors (TLRs) are crucial for recognition of pathogen-associated mo...
Background Toll-like receptors (TLRs) are crucial for recognition of pathogen-associated molecular p...
Toll-like receptors (TLRs) are crucial for recognition of pathogen-associated molecular patterns by ...
The use of antiretroviral therapy in HIV type 1 (HIV-1)–infected patients does not lead to virus era...
The persistence of latently HIV-infected cells in patients under combined anti-retroviral treatment ...
Background: The latent HIV-1 reservoir in treated patients primarily consists of resting memory CD4 ...
Background: The latent HIV-1 reservoir in treated patients primarily consists of resting memory CD4+...
BACKGROUND: During combined anti-retroviral treatment, a latent HIV reservoir persists within restin...
Highly active antiretroviral therapy (HAART) can reduce plasma HIV-1 levels in infected individuals ...
The biomolecular mechanisms controlling latent HIV-1 infection, despite their importance for the dev...
Background: Combination antiretroviral therapy (cART) is able to control HIV-1 viral replication, ho...
The search for an HIV-1 cure has been greatly hindered by the presence of a viral reservoir that per...
Latent HIV-1 proviruses are capable of reactivating productive lytic infection, but the precise mole...
Combination antiretroviral therapy (cART) can effectively suppress HIV-1 replication, but the latent...
Combination antiretroviral therapy (cART) can effectively suppress HIV-1 replication, but the latent...